Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway

Cisplatin is a commonly used drug for cancer treatment by crosslinking DNA, leading to apoptosis of cancer cells, resistance to cisplatin treatment often occurs, leading to relapse. Therefore, there is a need for the development of more effective treatment strategies that can overcome chemoresistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: HUANG, HAIZHI, CHEN, ALLEN Y., YE, XINGQIAN, LI, BINGYUN, ROJANASAKUL, YON, RANKIN, GARY O., CHEN, YI CHARLIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583523/
https://www.ncbi.nlm.nih.gov/pubmed/26315556
http://dx.doi.org/10.3892/ijo.2015.3133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583523/
https://www.ncbi.nlm.nih.gov/pubmed/26315556
http://dx.doi.org/10.3892/ijo.2015.3133

Ejemplares similares